Project Grant R01DK144044
Award Date 8/24/26
Completion Date 5/31/31
Dollars Obligated $777K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $786,728 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize gut microbiota-derived metabolic signaling pathways that regulate thermogenic fat cell formation and energy homeostasis in obesity. The funded research investigates 3-phenylpropionic acid (3-PPA), a gut microbiota-derived metabolite, as a promoter of beige...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Chicago $123,000 on June 16, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to characterize adipocyte heterogeneity and response to metabolic stress. The funded research uses single-nucleus RNA sequencing and a humanized mouse model to investigate how diverse stimuli influence white adipocyte development and specification, with emphasis on...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Cincinnati Children's Hospital Medical Center $771,701 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to delineate the impact of beige adipocytes in whole-body energy metabolism. The funded research addresses a gap in understanding adipose tissue biology by investigating the role of beige adipocytes in energy expenditure and metabolic health. Using a novel...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Chicago $6.511 million on September 20, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate macrophage roles in weight loss-induced metabolic health and adipose tissue inflammation resolution. The research examines how caloric restriction promotes a pro-resolving macrophage phenotype (termed CR-macrophages) that accumulates in visceral and...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Maryland Baltimore County $249,000 on July 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the role of macrophage-derived transglutaminases in adipose tissue health and inflammation during obesity. The research will examine how transglutaminases—enzymes involved in extracellular matrix remodeling and immune regulation—drive...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $1,634,996 to Boston University (Trustees of Boston University, doing business as Boston University Medical Campus) on February 18, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on vasculature and beige remodeling of obese adipose tissue. The research investigates how beige adipocyte recruitment and enhanced angiogenesis can counteract unhealthy...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The University of Texas Southwestern Medical Center $813,299 on August 24, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct basic biomedical research on the regulation of obesity-related inflammation by alpha-melanocyte-stimulating hormone (α-MSH). The research investigates the role of α-MSH in coordinating immune and metabolic responses to inflammatory...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Duke University $790,119 on August 26, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate how memory formation in adipose tissue influences metabolic outcomes in obesity. The project, titled "Establishing Memory in Adipose Tissue Influences Future Metabolic Outcomes in Obesity," examines the mechanisms that drive divergent remodeling of white...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Trustees of Tufts College (doing business as Tufts University School of Medicine) $232,000 on March 12, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the role of adipocyte interferon regulatory factor 8 (IRF8) in adipocyte and systemic metabolism and diet-induced obesity. The funded research will define the specific role of IRF8 in white and brown...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University $720,353 on March 25, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Assistance Listing Project Grant R01DK141555). The award funds research to identify and elucidate the functioning of hypothalamic neural circuits that regulate energy balance and metabolism, with focus on obesity-associated metabolic diseases. The research targets a...